Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3x Shares is trading at $13.94 per share. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3x Shares total debt is unavailable.

Amid political grandstanding and valuation concerns, among other factors, the once high-flying healthcare sector has swiftly reversed course for the worse in recent weeks. The pain has been especially ...

Linear IgA bullous dermatosis (LABD) is an autoimmune disease that causes blisters. People with LABD can develop blisters in the skin and the mucous membranes in their mouth, genitals, and eyelids.

The Direxion Daily S&P Biotech Bear 3X Shares ETF offers -3X daily leverage to the S&P Biotechnology Select Industry Index, primarily attracting short-term traders. LABD has lost 99.98% of its value ...

Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don’t foresee this fund generating positive growth in the near future, either.

No one really knows if presidential candidate Hillary Clinton has a position in the market. What the investment community does know is that Clinton's tweet about pharmaceuticals price gouging gave ...

Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the Direxion Daily S&P Biotech Bear 3X Shares, where 4,050,000 ...

The Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA: LABU) and Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA: LABD) ETFs have their place in a trading strategy. They can even be used as very ...

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the ProShares UltraShort S&P500 ( SDS), which added 13,950,000 units, or ...

After a third-quarter swoon that saw the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) and the SPDR S&P Biotech ETF (NYSE: XBI), two of the largest biotech exchange traded funds by assets, tumble ...